Focus: Arcturus Therapeutics is a San Diego-based biotech company specializing in lipid nanoparticle (LNP) mRNA drug delivery systems for cardiovascular and gene therapy indications. The company operates as a clinical-stage biotech with a diverse pipeline spanning infectious disease, genetic disorders, and rare metabolic conditions.
Profile data last refreshed 23h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Arcturus Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Arcturus Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Arcturus Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+1 more
+2 more
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles